SCHEMBL1649877

SCHEMBL1649877

O=C1C=CCc2c1c1cccc3c1n2C=CC3

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11542044 0.67 ALKBH5 (0.37)
SCHEMBL530252 0.64 HTR1A (0.36)
SCHEMBL9321634 0.63 ADORA2A (0.37)
SCHEMBL29720311 0.63 GRIA1 (0.35)
SCHEMBL13346263 0.61 CES1 (0.46)
SCHEMBL50865 0.58 MAOA (0.50)
SCHEMBL30252635 0.58 MAOA (0.50)
SCHEMBL341861 0.57 CYP1A2 (0.41)
Hydrochloric Acid SCHEMBL30537100 0.56 MAOA (0.48)
Hydrochloric Acid SCHEMBL2710069 0.56 MAOA (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1239882-B1 FORMULATIONS OF ADENOSINE A1 AGONISTS AND 5HT3 AGONISTS GLAXO GROUP LTD (GB) 2004-09-29 EP claimed
US-7927613-B2 Pharmaceutical co-crystal compositions UNIVERSITY OF SOUTH FLORIDA (US) 2011-04-19 US disclosed
EP-1239882-B1 FORMULATIONS OF ADENOSINE A1 AGONISTS AND 5HT3 AGONISTS GLAXO GROUP LTD (GB) 2004-09-29 EP disclosed
US-20030018008-A1 Formulations of adenosine a1 agonists BOUNTRA CHARANJIT (GB) 2003-01-23 US disclosed
EP-0851756-B1 USE OF ONDANSETRON IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF TREMOR GLAXO GROUP LTD (GB) 2003-01-15 EP disclosed